Creso’s acquisition of Halucenex Ltd exposes Australian investors to a market opportunity estimated to be worth US$100 billion. Creso Pharmaceuticals… Read More…..
Excerpt only …
READ MORE BELOW
Source : Press Release – Australia: Creso Pharma makes history as first ASX-listed psychedelics stock
reposted by Cannabis News World